Viridian Therapeutics, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC Beetham Thomas W. Chief Operating Officer +5K $23.41 +$117.05K
    SEC Mahoney Stephen F. President and CEO +21K $23.33 +$499.26K
    SEC Meisner Lara Chief Legal Officer -2.3K $28.02 -$64.33K
    SEC Meisner Lara Chief Legal Officer -7.5K $24.82 -$186.15K
    SEC Myers Scott Dunseth Chief Executive Officer +4K $25.37 +$101.48K
    SEC Myers Scott Dunseth Chief Executive Officer +5.5K $29.15 +$160.33K
    SEC Meisner Lara General Counsel and Secretary -30K $29.07 -$871.26K
    SEC Violin Jonathan Chief Executive Officer -50K $36.80 -$1.84M
    SEC Meisner Lara General Counsel and Secretary -17K $29.15 -$493.39K
    SEC Meisner Lara General Counsel and Secretary -1.6K $28.37 -$45.31K
    SEC Meisner Lara General Counsel and Secretary -16K $28.12 -$457.12K
    SEC Fairmount Healthcare Fund II L.P. N/A +426K $23.50 +$10.00M
    SEC Violin Jonathan Chief Executive Officer -30K $12.20 -$366.00K
    SEC Violin Jonathan Chief Executive Officer -30K $13.04 -$391.20K
    SEC Violin Jonathan Chief Executive Officer -30K $18.92 -$567.60K
    SEC Violin Jonathan Chief Executive Officer -30K $17.65 -$529.50K
    SEC Violin Jonathan Chief Executive Officer -30K $19.09 -$572.70K
    SEC FHMLSP, L.L.C. N/A +200K $11.00 +$2.20M
    SEC Fairmount Healthcare Fund II L.P. N/A +909K $11.00 +$10.00M

    Notifications